Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Revenue
Revenue		$ 18,180	$ 20,209
Cost of Revenue:
Total cost of revenue		7,196	10,261
Gross Profit		10,984	9,948
Operating Expenses
Selling, general and administrative		12,427	15,324
Research and development		3,550	3,850
Amortization of acquisition-related assets		867	1,054
Total operating expenses		16,844	20,228
Loss from operations		(5,860)	(10,280)
Interest expense, net		(4,657)	(4,414)
Other income (expense), net		3,454	(2,505)
Loss from related party equity method investment	[1]	(1,784)	(2,210)
Loss from continuing operations before income taxes		(8,847)	(19,409)
Provision for income taxes		93	226
Net loss from continuing operations		(8,940)	(19,635)
Income (loss) from discontinued operations, net of tax		32,005	(288)
Net income (loss)	[1]	$ 23,065	$ (19,923)
Basic and diluted net income (loss) per share
Continuing operations - common stock (in usd per share)		$ (0.08)	$ (0.18)
Discontinued operations - common stock (in usd per share)		0.29	0.00
Total net income (loss) per share - common stock (in usd per share)		$ 0.21	$ (0.18)
Weighted average shares outstanding
Basic and diluted - common stock (shares)		110,619,780	109,904,336
Total software-related revenue
Revenue
Revenue		$ 18,121	$ 17,802
Cost of Revenue:
Total cost of revenue		6,844	7,011
Software-as-a-service related
Revenue
Revenue		18,121	17,802
Cost of Revenue:
Total cost of revenue		5,701	5,708
Maintenance
Cost of Revenue:
Total cost of revenue		0	70
Amortization of developed technologies
Cost of Revenue:
Total cost of revenue		1,143	1,233
Sequencing and molecular analysis
Revenue
Revenue		59	814
Cost of Revenue:
Total cost of revenue		352	2,427
Home health care services
Revenue
Revenue		0	1,593
Cost of Revenue:
Total cost of revenue		$ 0	$ 823

[1] The statements for the three months ended March 31, 2020 and 2019 include the Connected Care Business (see Note 4).